Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

PER2 regulation of mammary gland development.

McQueen CM, Schmitt EE, Sarkar TR, Elswood J, Metz RP, Earnest D, Rijnkels M, Porter WW.

Development. 2018 Mar 14;145(6). pii: dev157966. doi: 10.1242/dev.157966.

2.

A vimentin binding small molecule leads to mitotic disruption in mesenchymal cancers.

Bollong MJ, Pietilä M, Pearson AD, Sarkar TR, Ahmad I, Soundararajan R, Lyssiotis CA, Mani SA, Schultz PG, Lairson LL.

Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):E9903-E9912. doi: 10.1073/pnas.1716009114. Epub 2017 Oct 30.

3.

The H3K27me3-demethylase KDM6A is suppressed in breast cancer stem-like cells, and enables the resolution of bivalency during the mesenchymal-epithelial transition.

Taube JH, Sphyris N, Johnson KS, Reisenauer KN, Nesbit TA, Joseph R, Vijay GV, Sarkar TR, Bhangre NA, Song JJ, Chang JT, Lee MG, Soundararajan R, Mani SA.

Oncotarget. 2017 Jul 10;8(39):65548-65565. doi: 10.18632/oncotarget.19214. eCollection 2017 Sep 12.

4.

Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT.

Mitra S, Federico L, Zhao W, Dennison J, Sarkar TR, Zhang F, Takiar V, Cheng KW, Mani S, Lee JS, Mills GB.

Oncotarget. 2016 Jun 28;7(26):40252-40265. doi: 10.18632/oncotarget.9730.

5.

GD2 and GD3 synthase: novel drug targets for cancer therapy.

Sphyris N, Sarkar TR, Battula VL, Andreeff M, Mani SA.

Mol Cell Oncol. 2015 Mar 9;2(3):e975068. doi: 10.4161/23723556.2014.975068. eCollection 2015 Jul-Sep.

6.

Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth.

Werden SJ, Sphyris N, Sarkar TR, Paranjape AN, LaBaff AM, Taube JH, Hollier BG, Ramirez-Peña EQ, Soundararajan R, den Hollander P, Powell E, Echeverria GV, Miura N, Chang JT, Piwnica-Worms H, Rosen JM, Mani SA.

Oncogene. 2016 Nov 17;35(46):5977-5988. doi: 10.1038/onc.2016.203. Epub 2016 Jun 13.

7.

Identification, Recombinant Expression, and Biochemical Analysis of Putative Secondary Product Glucosyltransferases from Citrus paradisi.

Devaiah SP, Owens DK, Sibhatu MB, Sarkar TR, Strong CL, Mallampalli VK, Asiago J, Cooke J, Kiser S, Lin Z, Wamucho A, Hayford D, Williams BE, Loftis P, Berhow M, Pike LM, McIntosh CA.

J Agric Food Chem. 2016 Mar 9;64(9):1957-69. doi: 10.1021/acs.jafc.5b05430. Epub 2016 Feb 29.

PMID:
26888166
8.

GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer.

Sarkar TR, Battula VL, Werden SJ, Vijay GV, Ramirez-Peña EQ, Taube JH, Chang JT, Miura N, Porter W, Sphyris N, Andreeff M, Mani SA.

Oncogene. 2015 Jun 4;34(23):2958-67. doi: 10.1038/onc.2014.245. Epub 2014 Aug 11.

9.

Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance.

Putluri N, Maity S, Kommagani R, Creighton CJ, Putluri V, Chen F, Nanda S, Bhowmik SK, Terunuma A, Dorsey T, Nardone A, Fu X, Shaw C, Sarkar TR, Schiff R, Lydon JP, O'Malley BW, Ambs S, Das GM, Michailidis G, Sreekumar A.

Neoplasia. 2014 May;16(5):390-402. doi: 10.1016/j.neo.2014.05.007. Erratum in: Neoplasia. 2014 Aug;16(8):678. Kommangani, Ramakrishna [corrected to Kommagani, Ramakrishna].

10.

FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.

Hollier BG, Tinnirello AA, Werden SJ, Evans KW, Taube JH, Sarkar TR, Sphyris N, Shariati M, Kumar SV, Battula VL, Herschkowitz JI, Guerra R, Chang JT, Miura N, Rosen JM, Mani SA.

Cancer Res. 2013 Mar 15;73(6):1981-92. doi: 10.1158/0008-5472.CAN-12-2962. Epub 2013 Feb 1.

11.

Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.

Sarkar TR, Sharan S, Wang J, Pawar SA, Cantwell CA, Johnson PF, Morrison DK, Wang JM, Sterneck E.

Mol Cell Biol. 2012 Jan;32(2):320-32. doi: 10.1128/MCB.05790-11. Epub 2011 Oct 28.

12.

CCAAT/enhancer binding protein delta (C/EBPdelta, CEBPD)-mediated nuclear import of FANCD2 by IPO4 augments cellular response to DNA damage.

Wang J, Sarkar TR, Zhou M, Sharan S, Ritt DA, Veenstra TD, Morrison DK, Huang AM, Sterneck E.

Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16131-6. doi: 10.1073/pnas.1002603107. Epub 2010 Aug 30.

13.

C/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression.

Pawar SA, Sarkar TR, Balamurugan K, Sharan S, Wang J, Zhang Y, Dowdy SF, Huang AM, Sterneck E.

Proc Natl Acad Sci U S A. 2010 May 18;107(20):9210-5. doi: 10.1073/pnas.0913813107. Epub 2010 May 3.

14.
15.

Carboxyl-coated magnetic nanoparticles for mRNA isolation and extraction of supercoiled plasmid DNA.

Sarkar TR, Irudayaraj J.

Anal Biochem. 2008 Aug 1;379(1):130-2. doi: 10.1016/j.ab.2008.04.016. Epub 2008 Apr 10.

PMID:
18471426

Supplemental Content

Loading ...
Support Center